| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |